Case studies A 3-stage segmentation analysis for understanding physician behaviour Side effect concerns have a major effect on treatment for HCV, negatively impacting the ability to initiate interferon IFN therapy or to maintain the optimal IFN dosing. Our client has a product to treat a specific side effect, and as IFN-free regimens are on the horizon, there is only a short window of opportunity to market the product. As such the most effective and efficient communication should highly targeted to customer needs.
A patient journey framework can help marketers find new touchpoints and proactively establish awareness, enhance connections, and affect behavior change. This approach can keep pharma companies one step ahead of competitors and help establish deeper relationships with patients and the people who influence their choices.
Our panel will discuss how technology, inspired startups, consumer demand and the regulatory environment is improving the standard of virtual care and how pharma brands can position themselves on the front lines of this trend. Before our brands can accomplish their business goals, our customers need to be able to accomplish theirs.
User experience and user-centric design are critical. So how do we harness the transformative power of digital technology to provide customer-centric digital experiences that drive value for our patients and our brands?
We will discuss Customer Engagement — what it is, why it matters and how to map the impact to business imperatives. Outcome Health will showcase a current collaboration focused on changing treatment patterns and delivering measurable outcomes at the point of care nationwide.
This presentation will discuss: The evolution of the adherence landscape through a data-driven lens The creation of the leading medication management platform to support patients across the healthcare spectrum How to close the claims information gap with real-world, real-time data Methods for working within existing Pharma structures to engage patients successfully Insights on how one top Pharma company took advantage of real-world, real-time data to identify opportunities to improve patient outcomes Omri Shor, CEO, MEDISAFE 3: After launching a new community for chronic granulomatous disease, a rare disease affecting fewer than 2, people in the U.
The Power of Mobile, Data, and Intelligent Messaging to Engage at the Point of Care and Beyond Mobile has already proven itself as a legitimate way to drive awareness — including for branded medications.
3M Health Information Systems (HIS) is using AWS Service Catalog to reduce time to market, engineer and provision development pipelines in minutes, and meet corporate governance, security, and compliance requirements. 3M HIS is a worldwide provider of software for the healthcare industry. Global healthcare market research and consulting for pharma, biotech and medical devices. Research Partnership is one of the largest independent healthcare market research and consulting agencies in the world. This case study reveals how we undertook a 3-stage segmentation analysis in order to exploit the market opportunity for a product with a limited timeframe.
It also represents a logical approach for engaging people further downstream in their relationship with a brand to drive adherence to a branded therapy.
Learn how our approach to driving awareness and adherence through distinct yet complementary areas of our mobile business has the power to engage consumer and HCP audiences to drive lift and loyalty. Join this session to discover how an effective and centralized solution for managing customer data can help you: Opposing Viewpoints on Leveraging Social Media for Effective Communication In this session, we will explore real world examples of the effective use of social media, from listening and monitoring, to moderation, to what went right and where we have fallen short but picked ourselves up again.
In order to meet the digital demands of this new empowered patient, Pharma marketing must evolve from a one-size fits all marketing approach to a marketing to one approach that focuses on the patient. In order to do this effectively, Marketers need to leverage AI and emerging technologies to learn and predict how a patient would like to interact with your brand.
But, in an industry where this type of marketing is still new, it is important that Pharma looks outside the industry to learn how other industries are succeeding.
In this session, we will look at examples from Retail, Consumer Products, and Pharma Manufacturers harnessing the power of AI to better their brand.
Our Life Sciences experts will dissect these examples to help you better understand how they can be applied to your marketing strategy. The need for online communities for women to share stories and experiences in order to help facilitate difficult conversations and advocate for their health is increasing.
Why Partnering and Business Models Enable the Future of Patient Care Identifying new products and services relevant to neurology patients Cultivating partnerships and pursuing strategic opportunities with mission-driven companies Design new business models orientated towards increased value delivery to health systems, improved patient experience and outcomes James Musick, Vice President, Head of Neurology Patient Technology U.
Are pharma companies ONLY In the business of discovery, development, commercialization of new medicines? OR are we in the health outcomes business? Those are two fundamentally different things and involve the broader services, technologies, and tools that could help patients do more, feel better or live longer: If so, you will not see transformation.
Balancing overall enterprise efforts including corporate AND individual brands. Is it one OR the other? General lessons learned in the transformation process? Advertising legends illustrate the importance of market research and branding Malcolm Gladwell: NY Times best-selling author on how to find the story Roger Federer: All-time tennis great on how to change as market conditions and competitors change Vince Lombardi: Super Bowl-winning coach and the importance of discipline Steve Jobs: This is increasingly important in the age of Cambridge Analytica, where trust of advertisers and the origins of their data have been called into question.
From implicit and explicit messages to the perceived trustworthiness of each platform, there are factors and dependencies that can increase the probability of conversion with digital pharma ads.
You will also learn how this research can be applied to organic content for broader pharma social campaigns and community building. Understanding the macro issues and how the sector is being disrupted at a global level Developing an effective transformation strategy and vision: Road map, buy-in, digital focus, investment and change management Using digitalization and new technologies like Artificial Intelligence to create innovative and sustainable solutions for customers Melissa Saw, Global Head of Digital Partnerships, BAYER 3: Marketers have spent countless hours uncovering deep insights about their core target audience.
These insights have been the primary driver in creating meaningful creative messaging but are often forgotten, or dismissed, when it comes to building out media campaigns. This is a miss. Pharmaceutical marketing has rightly or wrongly been positioned as the backwoods cousin of other industries when it comes to digital marketing innovation.Asia’s first Digital Pharma Conference center stages latest digital transformation trends and tech developments in pharmaceutical industry, and gathering of industry key players showcasing digital strategies.
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by the British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products.
It was published in the UK in September by the . Vacancy for Junior Research Fellow, Senior Research Fellow at NIAB Post Graduate Degree in Life Sciences (Biotechnology, Biochemistry, Microbiology, Etc.) or Post Graduate degree in professional courses (M.
Tech in Life Sciences, M. VSc.
Etc.). The recent rise of specialty pharma is attributed to its flexible, versatile, and open business model while the traditional big pharma is facing a challenging time with patent cliff, generic threat, and low research and development (R&D) productivity.
Meticulous Research is one of the best market research company providing global syndicated market research reports, custom research reports, and consulting services. We are recognized as one of the top market research firms providing research reports for healthcare, medical devices, agriculture, biotechnology, pharmaceutical, food and beverage, along with other industry research .
Our pharmaceutical industry analysis combines surveys, interviews, primary and secondary research methodologies, and pharma competitive intelligence to offer a holistic approach to tackling business challenges faced by our clients in the pharmaceutical industry.